# Yuviwel

NDC: 73362-201
Generic name: Navepegritide
Labeler / Manufacturer: Ascendis Pharma Endocrinology, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: KIT
Routes: —
Marketing started: 20260227

FDA application: NDA219164

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"73362-201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=73362-201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e01c1197-338f-414c-b804-808e129ebc8c